QSAR study of the peptidic fibrinogen inhibitors FK633, FR158999 and related derivatives, using a novel and useful hydrophobic descriptor (logPmw)
- Bioorg Med Chem Lett. 1998 Sep 22;8(18):2483-8. doi: 10.1016/s0960-894x(98)00405-3.
- 1. Basic Research Laboratories, Fujisawa Pharmaceutical Co. Ltd., Osaka, Japan.
A QSAR study using the novel hydrophobic descriptor (logPmw), which is a descriptor for membrane affinity, of our fibrinogen inhibitors FK633 (1), FR158999 (21), and related derivatives was performed, and resulted in good correlation (n = 19, s = 0.268, F = 6.38**, r = 0.667). Based on these results, we constructed a hypothesis by which these potent inhibitors bind to the receptor via the biomembrane and the C-terminal moiety functions as an anchor moiety.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: IntegrinResearch Areas: Cardiovascular Disease